ArticleMolecular cancer2024

Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patients.

Xiaohang Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.